Bernstein Liebhard LLP Comments on Recent Order in Philadelphia Court of Common Pleas That Affects Numerous Risperdal Lawsuits
New York, NY (PRWEB) March 15, 2015 -- Attorneys at Bernstein Liebhard LLP comments on the filing of a court order on March 9th, 2015 that indicates several Risperdal lawsuits (http://www.risperdallawsuit2014.com/) will be voluntarily dismissed without prejudice from the Philadelphia Court of Common Pleas pending the outcome of the appeal taken in a separate case against the drug’s manufacturer.
Plaintiffs in these Risperdal lawsuits, which have been filed in a consolidated litigation underway in the Philadelphia Court of Common Pleas, allege gynecomastia and other complications that allegedly occurred due to their use of Risperdal, which is manufactured by Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals. Attorneys at Bernstein Liebhard LLP are filing similar lawsuits over the medication, court records indicate. (In Re: Risperdal Litigation, Case Number 100300296)
"The Court's recent Order is significant because it means that more progress is occurring in the consolidated Risperdal litigation underway in the Philadelphia Court of Common Pleas. A flurry of updates involving Risperdal lawsuits continues to be issued in this proceeding, the first one involving a victory in February for the plaintiff in the proceeding’s first bellwether trial,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal evaluations to men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of Risperdal.
Risperdal Lawsuits
Just a few weeks before the Philadelphia Court of Common Pleas issued the above Order pertaining to certain Risperdal plaintiffs, court documents indicate that a verdict was reached in the litigation’s first bellwether trial. Jurors overhearing arguments in the case, which involved a 20-year old autistic man who blamed Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, for the gynecomastia injuries he developed as a child taking the medication, awarded him $2.5 million in February 2014 to compensate for his injury-related damages. This was the first trial involving a Risperdal gynecomastia case to conclude in the Pennsylvania litigation, court documents indicate. (Case No. A-196444)
According to statistics published by The Pennsylvania Record, 1,287 Risperdal lawsuits involving the antipsychotic drug were pending in the Philadelphia Court of Common Pleas as of March 6, 2015.* Plaintiffs in these cases similarly allege serious and debilitating complications, including gynecomastia that resulted due to its use. Plaintiffs further accuse Johnson & Johnson and Janssen of concealing information about side effects related to Risperdal, which they failed to adequately warn doctors and patients about.
Risperdal patients who allegedly developed gynecomastia after taking the medication may be eligible to file their own lawsuits. Learn more about Risperdal gynecomastia and other complications, when you visit Bernstein Liebhard LLP’s website or call the Firm directly for a free and confidential case review: 800-511-5092.
*pennrecord.com/news/15821-risperdal-pelvic-mesh-suits-cause-spike-in-filings-at-philadelphias-mass-torts-program, Pennsylvania Record, February 19, 2015
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Sandy A. Liebhard, Esq.
info (at) consumerinjurylawyers (dot) com
http://www.risperdallawsuit2014.com/
https://plus.google.com/115936073311125306742?rel=author
Sandy A. Liebhard, Risperdal Gynecomastia Lawsuit Center, http://www.risperdallawsuit2014.com/, +1 800-511-5092, [email protected]
Share this article